Neutralization of BA.1 and BA.2 Omicron variants with monoclonal antibodies
A new research paper published as an early release manuscript in the Nature Medicine journal compares the sensitivity of this strain as well as the earlier Delta and the newer BA.2 to therapeutic mAbs.
Source: news-medical.net